| Application no. and date | 08781323.4 (espacenet) (Federated) (European Patent Register), 20080703 | | Patent/reg. no. and date | DK/EP 2170388, 20161012 | | Publication date | 20100407 | | Priority no. and date | US 948220 P, 20070706 | | EP pub. no. and date |
EP 2170388 20100407 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/154267 | | Inventor | BRISBANE, Charlene, E., 709 Swedeland Road
King of Prussia, PA 19406, US,
KETKAR, Amol, Sharad, 709 Swedeland Road
King of Prussia, PA 19406, US,
LASHMAR, Ulla, Tove, New Frontiers Science Park
Third Avenue
Harlow, Essex CM19 5AW, GB | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 9/00 (2006.01) , C07K 16/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Anti-CD20 antistofformuleringer | | Int. application no. | US2008069125 | | Int. publication no. | WO2009009407 | | Related patent (certificate) | CA 2021 00034 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
